CF PharmTech, Inc. — Investor Relations & Filings
Filings indexed
80
across all filing types
Latest filing
2026-05-05
Regulatory Filings
Country
HK
Hong Kong
Listing
HKEX
2652
CF PharmTech, Inc. is a commercial-stage specialty pharmaceutical company specializing in the research, development, manufacturing, and commercialization of complex drug delivery systems, primarily focusing on inhalation technologies. The company develops treatments for major respiratory conditions, including asthma, Chronic Obstructive Pulmonary Disease (COPD), and allergic rhinitis. Its core product platforms encompass Inhalation Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs), inhalation liquid preparations (nebulizers), and nasal sprays. The firm also leverages advanced formulation techniques, such as liposomes, to enhance drug efficacy and delivery.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| NEXT DAY DISCLOSURE RETURN | 2026-05-05 | English | |
| NEXT DAY DISCLOSURE RETURN | 2026-05-04 | English | |
| 2025 Environmental, Social and Governance Report | 2026-04-30 | English | |
| 2025 Annual Report | 2026-04-30 | English | |
| NEXT DAY DISCLOSURE RETURN | 2026-04-30 | English | |
| NEXT DAY DISCLOSURE RETURN | 2026-04-28 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 41372493 | NEXT DAY DISCLOSURE RETURN | 2026-05-05 | English | ||
| 40869494 | NEXT DAY DISCLOSURE RETURN | 2026-05-04 | English | ||
| 39090420 | 2025 Environmental, Social and Governance Report | 2026-04-30 | English | ||
| 39083797 | 2025 Annual Report | 2026-04-30 | English | ||
| 39062062 | NEXT DAY DISCLOSURE RETURN | 2026-04-30 | English | ||
| 37991777 | NEXT DAY DISCLOSURE RETURN | 2026-04-28 | English | ||
| 37399646 | NEXT DAY DISCLOSURE RETURN | 2026-04-27 | English | ||
| 36145217 | NEXT DAY DISCLOSURE RETURN | 2026-04-24 | English | ||
| 35737075 | NEXT DAY DISCLOSURE RETURN | 2026-04-23 | English | ||
| 35229316 | NEXT DAY DISCLOSURE RETURN | 2026-04-22 | English | ||
| 34743258 | NEXT DAY DISCLOSURE RETURN | 2026-04-21 | English | ||
| 34691867 | NEXT DAY DISCLOSURE RETURN | 2026-04-20 | English | ||
| 33902250 | NEXT DAY DISCLOSURE RETURN | 2026-04-09 | English | ||
| 33797095 | Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2026 | 2026-04-08 | English | ||
| 33154578 | NEXT DAY DISCLOSURE RETURN | 2026-04-02 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Aprogen Biologics Inc.
Develops and manufactures novel biologics and biosimilar an…
|
003060 | KR | Manufacturing |
|
Aprogen, Inc
Develops and manufactures biologic medicines, including bio…
|
007460 | KR | Manufacturing |
|
Aptabio Therapeutics Inc.
Develops drugs for intractable diseases by regulating oxida…
|
293780 | KR | Manufacturing |
|
Aptamer Sciences Inc
Clinical-stage company developing aptamer-based therapeutic…
|
291650 | KR | Manufacturing |
|
Aptorum Group Ltd
Clinical-stage biopharma developing therapeutics for oncolo…
|
APM | US | Manufacturing |
|
Aptus Pharma Limited
Develops and manufactures cardiovascular, metabolic, and ga…
|
544529 | IN | Manufacturing |
|
Aquestive Therapeutics, Inc.
Pharmaceutical company developing oral film medicines for C…
|
AQST | US | Manufacturing |
|
Arbutus Biopharma Corp
Clinical-stage biopharma company developing a functional cu…
|
ABUS | US | Manufacturing |
|
Arcellx, Inc.
A clinical-stage biotech company developing immunotherapies…
|
ACLX | US | Manufacturing |
|
Arctic Bioscience
Develops pharmaceutical and nutraceutical products from mar…
|
ABS | NO | Manufacturing |
CF PharmTech, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/50735/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=50735 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=50735 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=50735 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 50735}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for CF PharmTech, Inc. (id: 50735)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.